127 related articles for article (PubMed ID: 37722371)
1. Three-Dimensional Arterial Spin Labeling for the Evaluation of the Cerebral Hemodynamics in Ischemic and Hemorrhagic Moyamoya Disease.
Bian H; Zhang L; Wang J
Cerebrovasc Dis; 2024; 53(3):307-315. PubMed ID: 37722371
[TBL] [Abstract][Full Text] [Related]
2. Clinical assessment of cerebral hemodynamics in Moyamoya disease via multiple inversion time arterial spin labeling and dynamic susceptibility contrast-magnetic resonance imaging: A comparative study.
Qiao PG; Han C; Zuo ZW; Wang YT; Pfeuffer J; Duan L; Qian T; Li GJ
J Neuroradiol; 2017 Jul; 44(4):273-280. PubMed ID: 28168990
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of MR mTI-ASL and DSC-PWI in evaluating cerebral hemodynamics of patients with Moyamoya disease.
Zhang J; Xia C; Liu Y; Qian W; Peng W; Liu K; Li L; Zhao F; Li Z
Medicine (Baltimore); 2018 Oct; 97(41):e12768. PubMed ID: 30313089
[TBL] [Abstract][Full Text] [Related]
4. Correlation between Clinical Presentations and Hemodynamic Parameters Measured by Dynamic Susceptibility Contrast Magnetic Resonance Imaging in Adult Patients with Moyamoya Disease.
Hirai S; Inaji M; Tanaka Y; Hara S; Nariai T; Maehara T
J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2814-2820. PubMed ID: 28778721
[TBL] [Abstract][Full Text] [Related]
5. Differences in cerebral blood flow measurement using arterial spin labeling MRI between patients with moyamoya disease and patients with arteriosclerotic cerebrovascular disease.
Ueda Y; Tanaka Y; Hara S; Inaji M; Ishii K; Maehara T; Nariai T
Acta Radiol; 2023 Jan; 64(1):311-319. PubMed ID: 35037475
[TBL] [Abstract][Full Text] [Related]
6. Arterial spin-labeling MR imaging in Moyamoya disease compared with clinical assessments and other MR imaging findings.
Noguchi T; Kawashima M; Nishihara M; Hirai T; Matsushima T; Irie H
Eur J Radiol; 2013 Dec; 82(12):e840-7. PubMed ID: 24055185
[TBL] [Abstract][Full Text] [Related]
7. Arterial spin-labeling cerebral perfusion changes after revascularization surgery in pediatric moyamoya disease and syndrome.
Quon JL; Kim LH; Lober RM; Maleki M; Steinberg GK; Yeom KW
J Neurosurg Pediatr; 2019 Feb; 23(4):486-492. PubMed ID: 30738390
[TBL] [Abstract][Full Text] [Related]
8. Effect of delayed transit time on arterial spin labeling: correlation with dynamic susceptibility contrast perfusion magnetic resonance in moyamoya disease.
Yun TJ; Sohn CH; Han MH; Kang HS; Kim JE; Yoon BW; Paeng JC; Choi SH; Kim JH; Song IC; Chang KH
Invest Radiol; 2013 Nov; 48(11):795-802. PubMed ID: 23764569
[TBL] [Abstract][Full Text] [Related]
9. Significance of Quantitative Cerebral Blood Flow Measurement in the Acute Stage after Revascularization Surgery for Adult Moyamoya Disease: Implication for the Pathological Threshold of Local Cerebral Hyperperfusion.
Kameyama M; Fujimura M; Tashiro R; Sato K; Endo H; Niizuma K; Mugikura S; Tominaga T
Cerebrovasc Dis; 2019; 48(3-6):217-225. PubMed ID: 31812964
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Hemodynamics Before and After Revascularization in Hemorrhagic Moyamoya Disease: A Computed Tomography Perfusion Imaging Case Study.
Wang X; Chong Z; Guo X; Liu D; Sun Z; Chen Y; Gao L; Chen Y
World Neurosurg; 2019 Nov; 131():e277-e283. PubMed ID: 31351211
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of DSC-PWI and 3D-ASL in ischemic stroke patients.
Zhang SX; Yao YH; Zhang S; Zhu WJ; Tang XY; Qin YY; Zhao LY; Liu CX; Zhu WZ
J Huazhong Univ Sci Technolog Med Sci; 2015 Dec; 35(6):923-927. PubMed ID: 26670447
[TBL] [Abstract][Full Text] [Related]
12. Spatial coefficient of variation applied to arterial spin labeling MRI may contribute to predict surgical revascularization outcomes in pediatric moyamoya vasculopathy.
Tortora D; Scavetta C; Rebella G; Bertamino M; Scala M; Giacomini T; Morana G; Pavanello M; Rossi A; Severino M
Neuroradiology; 2020 Aug; 62(8):1003-1015. PubMed ID: 32415392
[TBL] [Abstract][Full Text] [Related]
13. [Multi-parameter arterial spin labeling versus dynamic magnetic-sensitive enhanced cerebral perfusion imaging for diagnosis of transient cerebral ischemic attack].
Xu Y; Lv JH; Ma L; Chen WJ; Lou X
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jun; 36(6):768-74. PubMed ID: 27320876
[TBL] [Abstract][Full Text] [Related]
14. Comparison of CBF Measured with Combined Velocity-Selective Arterial Spin-Labeling and Pulsed Arterial Spin-Labeling to Blood Flow Patterns Assessed by Conventional Angiography in Pediatric Moyamoya.
Bolar DS; Gagoski B; Orbach DB; Smith E; Adalsteinsson E; Rosen BR; Grant PE; Robertson RL
AJNR Am J Neuroradiol; 2019 Nov; 40(11):1842-1849. PubMed ID: 31694821
[TBL] [Abstract][Full Text] [Related]
15. The value of 3D pseudo-continuousarterial spin labeling perfusion imaging in moyamoya disease-Comparison with dynamic susceptibility contrast perfusion imaging.
Zhang H; Lu M; Liu S; Liu D; Shen X; Sheng F; Han C; Cai J
Front Neurosci; 2022; 16():944246. PubMed ID: 35992916
[TBL] [Abstract][Full Text] [Related]
16. Transit time corrected arterial spin labeling technique aids to overcome delayed transit time effect.
Yun TJ; Sohn CH; Yoo RE; Kang KM; Choi SH; Kim JH; Park SW; Hwang M; Lebel RM
Neuroradiology; 2018 Mar; 60(3):255-265. PubMed ID: 29288284
[TBL] [Abstract][Full Text] [Related]
17. Comparison of arterial spin labeling perfusion with dynamic susceptibility contrast perfusion in Moyamoya disease.
Yadav N; Pendharkar H; Gupta AK; Prasad C; Shukla D; Kandavel T; Bansal S
J Neurosci Rural Pract; 2023; 14(2):286-292. PubMed ID: 37181159
[TBL] [Abstract][Full Text] [Related]
18. Can combined high-resolution vessel wall imaging and multiple post-labeling delay 3D pseudo-continuous arterial spin labeling differentiate moyamoya disease from atherosclerotic moyamoya syndrome?
Guo Y; Dou W; Wang X; Wang X; Mao H; Chen K
Eur J Radiol; 2023 Dec; 169():111184. PubMed ID: 37931375
[TBL] [Abstract][Full Text] [Related]
19. Perfusion-weighted magnetic resonance imaging used in assessing hemodynamics following superficial temporal artery-middle cerebral artery bypass in patients with Moyamoya disease.
Li Z; Zhou P; Xiong Z; Ma Z; Wang S; Bian H; Chen J
Cerebrovasc Dis; 2013; 35(5):455-60. PubMed ID: 23735877
[TBL] [Abstract][Full Text] [Related]
20. Contemporary and emerging magnetic resonance imaging methods for evaluation of moyamoya disease.
Lehman VT; Cogswell PM; Rinaldo L; Brinjikji W; Huston J; Klaas JP; Lanzino G
Neurosurg Focus; 2019 Dec; 47(6):E6. PubMed ID: 31786551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
